Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
2.730
-0.040 (-1.44%)
Nov 21, 2024, 4:00 PM EST - Market closed

Trevi Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2016
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2016
Net Income
-44.32-29.07-29.15-33.94-32.76-26.05
Upgrade
Depreciation & Amortization
0.140.120.040.050.050.04
Upgrade
Other Amortization
0.390.570.520.60.23-
Upgrade
Loss (Gain) From Sale of Assets
-0.01----
Upgrade
Loss (Gain) From Sale of Investments
-1.42-2.13-0.83---
Upgrade
Stock-Based Compensation
3.212.252.332.542.421.13
Upgrade
Other Operating Activities
0.380.380.150.290.010.22
Upgrade
Change in Accounts Receivable
------0.37
Upgrade
Change in Accounts Payable
0.43-1.050.010.830.420.78
Upgrade
Change in Other Net Operating Assets
6.12-2.8-1.240.680.641.17
Upgrade
Operating Cash Flow
-35.07-31.71-28.18-28.95-29-23.09
Upgrade
Capital Expenditures
-0.05-0.14-0.16--0.03-0.01
Upgrade
Investment in Securities
15.2459.57-107.21---
Upgrade
Investing Cash Flow
15.1959.43-107.37--0.03-0.01
Upgrade
Long-Term Debt Issued
----14-
Upgrade
Long-Term Debt Repaid
--9.5-5.83---
Upgrade
Net Debt Issued (Repaid)
-0.13-9.5-5.83-14-
Upgrade
Issuance of Common Stock
10.151.85117.4321.233.1865.14
Upgrade
Other Financing Activities
-0.06-0.26-0.29-0.45-0.46-1.89
Upgrade
Financing Cash Flow
9.96-7.91111.3120.7816.7273.21
Upgrade
Net Cash Flow
-9.9119.81-24.24-8.17-12.3150.11
Upgrade
Free Cash Flow
-35.12-31.85-28.33-28.95-29.03-23.1
Upgrade
Free Cash Flow Per Share
-0.35-0.32-0.44-1.27-1.61-1.97
Upgrade
Cash Interest Paid
0.130.330.590.60.18-
Upgrade
Levered Free Cash Flow
-19.26-21.97-17.95-16.5-16.62-13.69
Upgrade
Unlevered Free Cash Flow
-19.65-22.3-17.74-16.35-16.56-13.69
Upgrade
Change in Net Working Capital
-7.193.331.26-1.36-1.31-1.81
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.